{"text": "A total of 457 individuals were screened for the study ( Figure 1 . )Of these , 338 were ineligible after screening and record review and 12 declined to participate .", "label": "", "metadata": {}, "score": "39.415638"}
{"text": "Of 457 individuals screened , a total of 107 participants were enrolled , with 56 and 51 randomly assigned to DAART and SAT , respectively .", "label": "", "metadata": {}, "score": "58.01794"}
{"text": "126 participants were screened ; 71 were randomized ( 48 to the Stribild group and 23 to the Atripla group ) .All randomized participants received at least 1 dose of study medication and comprised the safety and intent - to - treat ( ITT ) analysis sets .", "label": "", "metadata": {}, "score": "58.786613"}
{"text": "A total of 408\u00c2 patients were enrolled into the trial at 37\u00c2 study centers .Eighty - six patients without histologic confirmation of PCP were excluded from the efficacy analyses .", "label": "", "metadata": {}, "score": "60.79793"}
{"text": "Pre - Assignment Details .Significant events and approaches for the overall study following participant enrollment , but prior to group assignment .Total of 353 participants were screened ; only 73 were randomized and thus 280 were not enrolled : 146 of them did not have cognitive impairment , 55 of them lacked laboratory inclusion criteria , and 79 of them had \" others \" .", "label": "", "metadata": {}, "score": "61.378387"}
{"text": "Significant events and approaches for the overall study following participant enrollment , but prior to group assignment .A total of 580 participants were enrolled and randomized to treatment ; however one participant withdrew from the study before taking any medication .", "label": "", "metadata": {}, "score": "64.98208"}
{"text": "Last participant visit : .Significant events and approaches for the overall study following participant enrollment , but prior to group assignment .126 participants were screened ; 71 were randomized ( 48 to the Stribild group and 23 to the Atripla group ) .", "label": "", "metadata": {}, "score": "69.09083"}
{"text": "Key information relevant to the recruitment process for the overall study , such as dates of the recruitment period and locations .Participants were enrolled in a total of 30 sites in the United States .", "label": "", "metadata": {}, "score": "70.90854"}
{"text": "Key information relevant to the recruitment process for the overall study , such as dates of the recruitment period and locations .Participants were enrolled at a total of 76 study sites ; 70 in the US , 3 in Canada , and 3 in Puerto Rico .", "label": "", "metadata": {}, "score": "72.98087"}
{"text": "Study sample characteristics .A median of 14 participants were enrolled at each of the five participating OTPs ( range 8 to 39 ) .Study participants were predominantly African American , approximately half were women , and the median age was 47 years ( Table 1 . )", "label": "", "metadata": {}, "score": "73.42036"}
{"text": "Compared to participants enrolled to the trial , the 12 individuals who declined to participate were more likely to be from site 4 and less likely to be African American ( Table ) .", "label": "", "metadata": {}, "score": "74.42467"}
{"text": "The majority ( 9 ) of these subjects were from a single site , which was the only site that did not have on - site HIV or medical care .", "label": "", "metadata": {}, "score": "75.18649"}
{"text": "Key information relevant to the recruitment process for the overall study , such as dates of the recruitment period and locations .81 participants enrolled 05/2010 - 10/2012 .", "label": "", "metadata": {}, "score": "75.85254"}
{"text": "Only 15 % of participants were employed .Participants had received medication - assisted therapy at the OTP for a median of 11 months prior to enrollment , with a median methadone dose of 90 mg or a median buprenorphine dose of 19 mg .", "label": "", "metadata": {}, "score": "76.11538"}
{"text": "Participants were enrolled in a total of 30 sites in the United States .The first participant was screened on 30 March 2009 .Last participant visit : .", "label": "", "metadata": {}, "score": "82.4506"}
{"text": "[5 ] .After the titration phase , 33 participants were randomized to the Aspart - PH20/Insulin lispro group .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "84.06531"}
{"text": "Prior to randomization , all enrolled participants underwent a titration period of 4 to 6 weeks in which they received 100 U / mL insulin glulisine , injected SC , pre - meals , with doses titrated to each participant individually .", "label": "", "metadata": {}, "score": "85.41113"}
{"text": "Significant events and approaches for the overall study following participant enrollment , but prior to group assignment .The study included an open - label titration period of at least 4 weeks and up to 6 weeks prior to randomization at Week 0 .", "label": "", "metadata": {}, "score": "85.45217"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .All participants in the study , including those who were enrolled but were not randomized .", "label": "", "metadata": {}, "score": "86.02905"}
{"text": "Participants were treated until disease progression , unacceptable toxicity , or consent withdrawal .Number of Participants Who Progressed or Died at or Prior to 6 Months , as a Measure of Six Months Progression - free Survival ( PFS )", "label": "", "metadata": {}, "score": "87.9422"}
{"text": "[ 1 ] .26 participants completed STEP1 ; however , only 19 out of the 26 decided to enroll in STEP2 .[ 2 ] .", "label": "", "metadata": {}, "score": "87.95996"}
{"text": "Description .All Study Participants .All participants in the study , including those who were enrolled but were not randomized .Percentage of Participants Meeting Glucose Targets at Least 2/3 of the Time .", "label": "", "metadata": {}, "score": "88.998375"}
{"text": "This study has a screening visit and five study visits .Two of the study visits will .last about 12 hours ; the other three visits will last about 1 hour each .", "label": "", "metadata": {}, "score": "89.59198"}
{"text": "Assignments were generated in blocks that randomly varied in size between 2 and 8 .The treatment assignment list was incorporated into a Microsoft Access - based program that revealed individual assignments sequentially as new participants were enrolled .", "label": "", "metadata": {}, "score": "90.853"}
{"text": "No site enrolled more than 7 % of participants .Reporting Groups .Description .Stribild .Stribild QD was administered during the extension phase .", "label": "", "metadata": {}, "score": "91.501945"}
{"text": "Recruitment was initially planned with a minimum of 490 participants anticipating that it would continue until a total of 172 participants reaching primary endpoint criteria is achieved .", "label": "", "metadata": {}, "score": "91.84302"}
{"text": "The assignment list was password protected and was not accessible to the research coordinator or research assistants , apart from revealing sequential treatment assignments at the times of randomization .", "label": "", "metadata": {}, "score": "92.18407"}
{"text": "c From 106 subjects .Twenty percent of subjects were ART na\u00efve at enrollment , and the prescribed regimen was dosed once daily in 61 % and twice daily in 39 % .", "label": "", "metadata": {}, "score": "93.3741"}
{"text": "This paper describes the rationale , methods , and baseline characteristics of subjects enrolled in a randomized clinical trial comparing DAART to SAT in opioid treatment programs .", "label": "", "metadata": {}, "score": "93.85928"}
{"text": "In the intent - to - treat analysis for all randomized patients , there were 11 ( 12.5 % ) deaths in the arm treated with MEPRON and 12\u00c2 ( 14 % ) deaths in the pentamidine arm .", "label": "", "metadata": {}, "score": "93.93698"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .Safety Analysis Set : participants were randomized and received at least 1 dose of study medication .", "label": "", "metadata": {}, "score": "94.202866"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .Safety Analysis Set : participants were randomized and received at least 1 dose of study medication .", "label": "", "metadata": {}, "score": "94.202866"}
{"text": "Pre - Assignment Details .Significant events and approaches for the overall study following participant enrollment , but prior to group assignment .Two additional participants consented , but withdrew prior to baseline testing .", "label": "", "metadata": {}, "score": "94.82889"}
{"text": "Thirty - nine patients without histologic confirmation of PCP were excluded from the efficacy analyses .Of the 135\u00c2 patients with histologically confirmed PCP , 70 were randomized to receive MEPRON and 65 to pentamidine .", "label": "", "metadata": {}, "score": "95.346535"}
{"text": "Actual median follow - up was 5.8 months .Pre - Assignment Details .Significant events and approaches for the overall study following participant enrollment , but prior to group assignment .", "label": "", "metadata": {}, "score": "96.53519"}
{"text": "Prevention of PCP .Dapsone Comparative Study .This randomized , open - label trial enrolled a total of 1,057 patients at 48\u00c2 study centers .", "label": "", "metadata": {}, "score": "96.76021"}
{"text": "PubMed View Article .Taiwo BO , Idoko JA , Marcelin AG , Otoh I , Reddy S , Iyaji PG , et al .: Patient - selected treatment partners did not protect against drug resistance during first - line NNRTI - based HAART in a randomized trial .", "label": "", "metadata": {}, "score": "97.60796"}
{"text": "The OTP censuses ranged from 153 to 1007 .All sites provided methadone maintenance therapy , and site 1 also provided buprenorphine maintenance therapy .Sites 1 and 5 had on - site HIV care available throughout the study , sites 2 and 3 had on - site HIV care available for part of the study period , and site 4 did not have on - site HIV - care services .", "label": "", "metadata": {}, "score": "97.77114"}
{"text": "PubMed View Article .Gross R , Tierney C , Andrade A , Lalama C , Rosenkranz S , Eshleman SH , et al .: Modified directly observed antiretroviral therapy compared with self - administered therapy in treatment - naive HIV-1-infected patients : a randomized trial .", "label": "", "metadata": {}, "score": "98.67856"}
{"text": "Active use of cocaine and other drugs was common at baseline .HIV disease stage was advanced in most participants .The median CD4 count at enrollment was 207 cells / mm 3 , 66 ( 62 % ) had a history of an AIDS - defining opportunistic condition , and 21 ( 20 % ) were antiretroviral na\u00efve .", "label": "", "metadata": {}, "score": "98.77464"}
{"text": "However , we chose not to enroll such participants because we were concerned that the intervention could have heterogeneous effects in individuals who were failing ( or not taking ) therapy and those who were doing well with treatment .", "label": "", "metadata": {}, "score": "99.17692"}
{"text": "Two other studies that assessed DAART interventions for 12 months were conducted in sub - Saharan Africa and used peers to observe dosing [ 25 , 28 ] .", "label": "", "metadata": {}, "score": "99.40015"}
{"text": "They will record doses and any symptoms on a diary card at home . -After 14 days , participants will have a 12-hour visit to provide blood samples .", "label": "", "metadata": {}, "score": "99.501785"}
{"text": "Berg KM , Mouriz J , Li X , Duggan E , Goldberg U , Arnsten JH : Rationale , design , and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics .", "label": "", "metadata": {}, "score": "99.65147"}
{"text": "Lost to Follow - up .[ 1 ] .Seven participants completing randomized Atripla treatment did not enter open - label extension phase .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "100.169495"}
{"text": "Lost to Follow - up .[ 1 ] .Seven participants completing randomized Atripla treatment did not enter open - label extension phase .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "100.169495"}
{"text": "Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "100.87619"}
{"text": "Therapy failures included lack of response , treatment discontinuation due to an adverse experience , and unevaluable .Among the 322\u00c2 patients with confirmed PCP , 13 of 160\u00c2 ( 8 % ) patients treated with MEPRON and 4 of 162 ( 2.5 % ) patients receiving TMP - SMX died during the 21-day treatment course or 8-week follow - up period .", "label": "", "metadata": {}, "score": "101.45892"}
{"text": "PubMed View Article .Berg KM , Litwin A , Li X , Heo M , Arnsten JH : Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics : A randomized controlled trial .", "label": "", "metadata": {}, "score": "101.46237"}
{"text": "Design .The study is a randomized , non - blinded trial comparing DAART and SAT in HIV - infected participants who are receiving medication assisted treatment at 1 of 5 OTPs in Baltimore , Maryland .", "label": "", "metadata": {}, "score": "101.53165"}
{"text": "Number of Participants With the Indicated Adverse Events ( AEs )With a Maximum Toxicity Grade of 3 or 4 [ Time Frame : Baseline ( Day 1 ) until 30 days after the last dose of randomized therapy ( average of 26 weeks ) ]", "label": "", "metadata": {}, "score": "101.672806"}
{"text": "Patients randomized to MEPRON were to receive 750\u00c2 mg atovaquone ( three 250-mg tablets ) 3 times daily for 21\u00c2 days and those randomized to pentamidine isethionate were to receive a 3- to 4-mg / kg single IV infusion daily for 21\u00c2 days .", "label": "", "metadata": {}, "score": "102.550934"}
{"text": "To address this question we designed a randomized controlled trial of DAART compared with SAT .In this paper we describe the rationale , methods , and baseline characteristics of subjects enrolled in our study .", "label": "", "metadata": {}, "score": "102.62151"}
{"text": "Study participants randomized to treatment with MEPRON were to receive 750\u00c2 mg MEPRON ( three 250-mg tablets ) 3 times daily for 21\u00c2 days and those randomized to TMP - SMX were to receive 320\u00c2 mg TMP plus 1,600\u00c2 mg SMX 3 times daily for 21\u00c2 days .", "label": "", "metadata": {}, "score": "102.686264"}
{"text": "Median follow - up was 11.3\u00c2 months .The results of the PCP event rates appear in Table 3 .There were no significant differences in mortality rates among the groups .", "label": "", "metadata": {}, "score": "104.020645"}
{"text": "Baseline through Week 24 , excluding 10-point glucose monitoring days .Safety Issue .No .Population Description .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "104.569664"}
{"text": "[ 3 ] .After the titration phase , 30 participants were randomized to the Lispro - PH20/Insulin lispro group .[ 4 ] .", "label": "", "metadata": {}, "score": "104.643425"}
{"text": "A recent study from the Bronx , New York , found that OTP - based DAART was associated with statistically significantly higher rates of adherence and viral suppression than SAT [ 6 ] .", "label": "", "metadata": {}, "score": "104.81473"}
{"text": "JAMA 1998 , 279 : 943 - 948 .PubMed View Article .Ford N , Nachega JB , Engel ME , Mills EJ : Directly observed antiretroviral therapy : a systematic review and meta - analysis of randomised clinical trials .", "label": "", "metadata": {}, "score": "104.86301"}
{"text": "AIDS 2007 , 21 : 1473 - 1477 .PubMed View Article .Altice FL , Maru DS , Bruce RD , Springer SA , Friedland GH : Superiority of directly administered antiretroviral therapy over self - administered therapy among HIV - infected drug users : a prospective , randomized , controlled trial .", "label": "", "metadata": {}, "score": "104.910255"}
{"text": "Additionally , we required verbal agreement to participate from participants ' HIV medical providers .Participant Recruitment .Research assistants , employed full - time at the sites and familiar with the OTP clients , were responsible for recruitment and initial screening of participants .", "label": "", "metadata": {}, "score": "105.27054"}
{"text": "Methods / Design .We are conducting a randomized trial comparing DAART to self - administered therapy ( SAT ) in 5 OTPs in Baltimore , Maryland .", "label": "", "metadata": {}, "score": "105.374405"}
{"text": "PubMed View Article .Nachega JB , Chaisson RE , Goliath R , Efron A , Chaudhary MA , Ram M , et al .: Randomized controlled trial of trained patient - nominated treatment supporters providing partial directly observed antiretroviral therapy .", "label": "", "metadata": {}, "score": "105.3972"}
{"text": "When addition of new study sites failed to fully rectify slow recruitment , we revised our primary outcome to viral suppression at three time points during active intervention ( 3 , 6 , and 12 months ) , rather than at a single time point ( 12 months ) .", "label": "", "metadata": {}, "score": "105.906845"}
{"text": "Our study has several strengths .First , our target population is HIV - infected drug users ( most with demonstrated non - adherence in previous treatment attempts ) .", "label": "", "metadata": {}, "score": "106.11899"}
{"text": "Design : . - Participants will be screened with a physical exam and medical history .They will also . have blood and urine tests .", "label": "", "metadata": {}, "score": "106.18528"}
{"text": "Atripla QHS and placebo to match Stribild QD were administered during the double blind phase .Stribild QD was administered during the extension phase .Cluster Determinant 4 ( CD4 ) Cell Count ( /\u00b5L ) [ units : participants ] .", "label": "", "metadata": {}, "score": "106.33991"}
{"text": "Atripla QHS and placebo to match Stribild QD were administered during the double blind phase .Stribild QD was administered during the extension phase .Cluster Determinant 4 ( CD4 ) Cell Count ( /\u00b5L ) [ units : participants ] .", "label": "", "metadata": {}, "score": "106.33991"}
{"text": "The study coordinator conducted all study visits .This was done to both standardize data collection and to foster candid responses from participants about medication adherence , substance use , and other sensitive issues .", "label": "", "metadata": {}, "score": "106.7516"}
{"text": "We follow participants to 18 months to assess the potential persistence of any benefits realized during the intervention period .Setting .We enrolled participants from 5 OTPs in Baltimore between May 2006 and May 2010 .", "label": "", "metadata": {}, "score": "106.96494"}
{"text": "Maru DS , Kozal MJ , Bruce RD , Springer SA , Altice FL : Directly administered antiretroviral therapy for HIV - infected drug users does not have an impact on antiretroviral resistance : results from a randomized controlled trial .", "label": "", "metadata": {}, "score": "106.97"}
{"text": "We conducted study visits at baseline , 3 , 6 , 12 , and 18 months .Study visits were conducted at OTPs and included an update of contact information , a face - to - face interview , and collection of blood and urine specimens .", "label": "", "metadata": {}, "score": "107.19212"}
{"text": "We also asked participants to sign releases for medical and substance abuse treatment records to permit confirmation of study eligibility and to record outcome data during the trial .", "label": "", "metadata": {}, "score": "107.30748"}
{"text": "No statistical analysis provided for The Percentage of Participants With HIV-1 RNA Less Than 50 Copies / mL at Week 48 .The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days .", "label": "", "metadata": {}, "score": "107.854836"}
{"text": "Table 1 .Baseline characteristics of HIV - infected participants enrolled in a randomized trial comparing directly administered antiretroviral therapy to self administered therapy in opioid treatment programs , Baltimore , Maryland .", "label": "", "metadata": {}, "score": "108.03612"}
{"text": "PubMed View Article .Maru DS , Bruce RD , Walton M , Springer SA , Altice FL : Persistence of virological benefits following directly administered antiretroviral therapy among drug users : results from a randomized controlled trial .", "label": "", "metadata": {}, "score": "108.1434"}
{"text": "Lucas GM , Mullen BA , Weidle PJ , Hader S , McCaul ME , Moore RD : Directly Administered Antiretroviral Therapy in Methadone Clinics Is Associated with Improved HIV Treatment Outcomes , Compared with Outcomes among Concurrent Comparison Groups .", "label": "", "metadata": {}, "score": "108.27021"}
{"text": "Participants were instructed to monitor their blood glucose levels a minimum of 4 times per day on all non-10-point glucose monitoring days .The number of participants was recorded , and the percentage of participants meeting glucose targets was calculated by the number of participants with values meeting the specified target at least 2/3 of the time by the total number of participants analyzed , multiplied by 100 .", "label": "", "metadata": {}, "score": "108.46231"}
{"text": "Participants in the control arm self - administer all doses .The primary outcome is viral load suppression , measured at 3 , 6 , and 12 months .", "label": "", "metadata": {}, "score": "108.76257"}
{"text": "We encountered lower prevalences of HIV at the OTPs than expected , although pre - study estimates were based on limited data .Additionally , once we had screened the population at an OTP , we were dependent on slot turnover for new candidates .", "label": "", "metadata": {}, "score": "108.82218"}
{"text": "This double - blind , randomized trial initiated in 1990 was designed to compare the safety and efficacy of MEPRON to that of TMP - SMX for the treatment of AIDS patients with histologically confirmed PCP .", "label": "", "metadata": {}, "score": "109.162415"}
{"text": "PubMed .Lucas GM , Griswold M , Gebo KA , Keruly J , Chaisson RE , Moore RD : Illicit drug use and HIV-1 disease progression : a longitudinal study in the era of highly active antiretroviral therapy .", "label": "", "metadata": {}, "score": "109.504"}
{"text": "The study hypothesized participants in the intervention arm would demonstrate improved total bone mineral content for height , spinal and tibial bone mineral density and tibial bone strength when compared to those who were randomized to the placebo arm .", "label": "", "metadata": {}, "score": "109.5832"}
{"text": "The study hypothesized participants in the intervention arm would demonstrate improved total bone mineral content for height , spinal and tibial bone mineral density and tibial bone strength when compared to those who were randomized to the placebo arm .", "label": "", "metadata": {}, "score": "109.5832"}
{"text": "PubMed .Goggin K , Liston RJ , Mitty JA : Modified directly observed therapy for antiretroviral therapy : a primer from the field .Public Health Rep 2007 , 122 : 472 - 481 .", "label": "", "metadata": {}, "score": "109.66669"}
{"text": "The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract , manuscript , or presentation form ; or Allocation : Randomized ; Endpoint Classification : Safety / Efficacy Study ; Intervention Model : Single Group Assignment ; Masking : Double Blind ( Subject , Caregiver , Investigator , Outcomes Assessor ) ; Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "109.98793"}
{"text": "PubMed View Article .Brust JC , Litwin AH , Berg KM , Li X , Heo M , Arnsten JH : Directly Observed Antiretroviral Therapy in Substance Abusers Receiving Methadone Maintenance Therapy Does Not Cause Increased Drug Resistance .", "label": "", "metadata": {}, "score": "110.006516"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .Participants in Treatment Period 1 or Treatment Period 2 who received at least 1 dose of study drug and had evaluable postprandial blood glucose data .", "label": "", "metadata": {}, "score": "110.058685"}
{"text": "Disposition of individuals screened for a trial comparing directly administered antiretroviral therapy to self - administered therapy in opioid treatment programs , Baltimore , Maryland .", "label": "", "metadata": {}, "score": "110.059906"}
{"text": "Lucas GM , Mullen BA , McCaul ME , Weidle PJ , Hader S , Moore RD : Adherence , drug use , and treatment failure in a methadone - clinic - based program of directly administered antiretroviral therapy .", "label": "", "metadata": {}, "score": "110.21382"}
{"text": "Power and Planned Statistical Analyses .We hypothesize that DAART will increase rates of viral suppression compared to SAT .At study outset , we planned to enroll 200 participants to provide 80 % power to detect a 20 % difference in HIV RNA suppression between the study arms at 12 months .", "label": "", "metadata": {}, "score": "110.34238"}
{"text": "Goldie SJ , Paltiel AD , Weinstein MC , Losina E , Seage GR III , Kimmel AD , et al .: Projecting the cost - effectiveness of adherence interventions in persons with human immunodeficiency virus infection .", "label": "", "metadata": {}, "score": "110.44396"}
{"text": "The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract , manuscript , or presentation form ; or Allocation : Randomized ; Endpoint Classification : Safety / Efficacy Study ; Intervention Model : Crossover Assignment ; Masking : Double Blind ( Subject , Caregiver , Investigator , Outcomes Assessor ) ; Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "111.014496"}
{"text": "We made concerted efforts to maintain contact with participants ( particularly if they left the OTP ) and made arrangements for study visits to be completed in another venue if preferred .", "label": "", "metadata": {}, "score": "111.569016"}
{"text": "PubMed View Article .Hart JE , Jeon CY , Ivers LC , Behforouz HL , Caldas A , Drobac PC , et al .: Effect of directly observed therapy for highly active antiretroviral therapy on virologic , immunologic , and adherence outcomes : a meta - analysis and systematic review .", "label": "", "metadata": {}, "score": "111.60861"}
{"text": "PubMed .Pearson CR , Micek MA , Simoni JM , Hoff PD , Matediana E , Martin DP , et al .: Randomized control trial of peer - delivered , modified directly observed therapy for HAART in Mozambique .", "label": "", "metadata": {}, "score": "112.05456"}
{"text": "One patient in the primary therapy group randomized to receive pentamidine did not receive study medication .There was no difference in mortality rates between the treatment groups .", "label": "", "metadata": {}, "score": "112.12958"}
{"text": "Reporting Groups .Description .Stribild .Stribild QD and placebo to match Atripla QHS were administered during the double - blind phase .Stribild QD was administered during the extension phase .", "label": "", "metadata": {}, "score": "112.44233"}
{"text": "A correlation between plasma atovaquone concentrations and death was demonstrated ; in general , patients with lower plasma concentrations were more likely to die .Sixty - two percent of patients on MEPRON and 64 % of patients on TMP - SMX were classified as protocol - defined therapy successes ( Table\u00c2 4 ) .", "label": "", "metadata": {}, "score": "112.80353"}
{"text": "Taiwo BO , Idoko JA , Welty LJ , Otoh I , Job G , Iyaji PG , et al . :Assessing the Viorologic and Adherence Benefits of Patient - Selected HIV Treatment Partners in a Resource - limited Setting .", "label": "", "metadata": {}, "score": "112.93277"}
{"text": "Participants were treated until disease progression , unacceptable toxicity , or consent withdrawal .Death .[ 1 ] .These participants have no completion status information recorded on the case report forms .", "label": "", "metadata": {}, "score": "113.366486"}
{"text": "PubMed View Article .Sarna A , Luchters S , Geibel S , Chersich MF , Munyao P , Kaai S , et al .: Short- and Long - Term Efficacy of Modified Directly Observed Antiretroviral Treatment in Mombasa , Kenya : A Randomized Trial .", "label": "", "metadata": {}, "score": "113.42874"}
{"text": "Additionally , we facilitated on - site HIV counseling and testing services at the sites to improve access to testing and to identify HIV - infected persons who were not aware of their status .", "label": "", "metadata": {}, "score": "113.48045"}
{"text": "Resistance to AP and ASAP will be assessed by a combination of clinical , pharmacologic , and parasitological parameters including genomic signatures of selection during careful weekly follow - up visits for 6 weeks .", "label": "", "metadata": {}, "score": "113.95347"}
{"text": "The second most common reason for exclusion was disengagement from HIV care , absence of active insurance coverage , or failure to obtain ART prescription , which accounted for 59 exclusions .", "label": "", "metadata": {}, "score": "114.32561"}
{"text": "One participant randomized to the TVD+PI / r group was never treated .Reporting Groups .Description .FTC / TDF ( Truvada [ TVD ] ) + PI / r ( Ritonavir - boosted PI Regimen ) .", "label": "", "metadata": {}, "score": "114.51637"}
{"text": "However , particularly at sites where on - site HIV care was not available , such efforts were often unsuccessful .This highlights the importance of addressing basic access and engagement to care in trials of medication adherence interventions .", "label": "", "metadata": {}, "score": "114.61525"}
{"text": "Dropout was higher than expected leading to small numbers for analysis .It was estimated that 30 persons were needed in each arm to detect a 5.5 % difference in change in bone outcomes between the active device and placebo device arms of the study .", "label": "", "metadata": {}, "score": "114.67023"}
{"text": "PubMed View Article .Arnsten JH , Demas PA , Grant RW , Gourevitch MN , Farzadegan H , Howard AA , et al .: Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV - infected drug users .", "label": "", "metadata": {}, "score": "115.389656"}
{"text": "To date , trials of DAART have yielded mixed findings regarding efficacy [ 2 , 3 ] .However , completed trials have varied considerably in setting , population studied , and method of delivering DAART .", "label": "", "metadata": {}, "score": "115.428986"}
{"text": "Randomization .To prevent knowledge of treatment assignment from influencing the selection of antiretroviral drugs , we required HIV providers to prescribe ART regimens prior to randomization .", "label": "", "metadata": {}, "score": "115.47041"}
{"text": "No text entered .Reporting Groups .Description .TVD + PI / r .Participants in this group received fixed - dose combination FTC 200 mg / TDF 300 mg ( Truvada [ TVD ] ) for 48 weeks .", "label": "", "metadata": {}, "score": "115.62413"}
{"text": "PubMed View Article .Wohl DA , Stephenson BL , Golin CE , Kiziah CN , Rosen D , Ngo B , et al .: Adherence to directly observed antiretroviral therapy among human immunodeficiency virus - infected prison inmates .", "label": "", "metadata": {}, "score": "115.64755"}
{"text": "Human Subjects Protection .The study was approved by the Johns Hopkins Medicine Institutional Review Board , the University of Maryland Baltimore Institutional Review Board , and the Veterans Administration Research and Development Committee .", "label": "", "metadata": {}, "score": "116.31619"}
{"text": "Description .Stribild .Stribild QD and placebo to match Atripla QHS were administered during the double - blind phase .Stribild QD was administered during the extension phase .", "label": "", "metadata": {}, "score": "116.50701"}
{"text": "Description .Stribild .Stribild QD and placebo to match Atripla QHS were administered during the double - blind phase .Stribild QD was administered during the extension phase .", "label": "", "metadata": {}, "score": "116.50701"}
{"text": "100 U / mL insulin lispro , injected SC , pre - meals , with doses titrated to each participant individually , for 12 weeks .", "label": "", "metadata": {}, "score": "116.67284"}
{"text": "An important limitation of our study is the relatively small sample size , which limits our ability to detect small , but potentially clinically meaningful , differences between study conditions .", "label": "", "metadata": {}, "score": "117.31607"}
{"text": "PubMed View Article .Conway B , Prasad J , Reynolds R , Farley J , Jones M , Jutha S , et al .: Directly observed therapy for the management of HIV - infected patients in a methadone program .", "label": "", "metadata": {}, "score": "117.9447"}
{"text": "In summary , we recently completed enrollment for a randomized controlled trial comparing DAART to SAT among HIV - infected participants attending OTPs .Important clinical questions remain about whether DAART is a useful adherence strategy , and if so , in which populations and under what implementation models .", "label": "", "metadata": {}, "score": "118.87166"}
{"text": "Clin Infect Dis 2006 , 42 : 1619 - 1627 .PubMed View Article .Macalino GE , Hogan JW , Mitty JA , Bazerman LB , Delong AK , Loewenthal H , et al .", "label": "", "metadata": {}, "score": "118.909775"}
{"text": "PubMed View Article .Wohl AR , Garland WH , Valencia R , Squires K , Witt MD , Kovacs A , et al .:", "label": "", "metadata": {}, "score": "118.91284"}
{"text": "After the wash - out period , participants will switch dose levels to either the high or .low dose . -After 14 days , participants will have a 12-hour visit to provide blood samples .", "label": "", "metadata": {}, "score": "119.017845"}
{"text": "The recruitment period was from Mar 2008 to Oct 2009 when the study was stopped early ( Data and Safety Monitoring Board ( DSMB ) decision based on futility ) on Nov 2009 .", "label": "", "metadata": {}, "score": "119.31676"}
{"text": "Lucas GM , Cheever LW , Chaisson RE , Moore RD : Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection .", "label": "", "metadata": {}, "score": "119.39824"}
{"text": "Atripla QHS and placebo to match Stribild QD were administered during the double blind phase .Stribild QD was administered during the extension phase .Measured Values .", "label": "", "metadata": {}, "score": "119.571045"}
{"text": "Pentamidine Comparative Study .This unblinded , randomized trial initiated in 1991 was designed to compare the safety and efficacy of MEPRON to that of pentamidine for the treatment of histologically confirmed mild or moderate PCP in AIDS patients .", "label": "", "metadata": {}, "score": "119.64736"}
{"text": "[ 1 ] .One participant did n't have a systemic - to - pulmonary artery shunt but underwent stenting of the right ventricular outflow track .", "label": "", "metadata": {}, "score": "119.66073"}
{"text": "Declarations .Acknowledgements .This study was supported by the National Institutes of Health ( R01 DA018577 , K23-DA15616 ) .Competing interests .", "label": "", "metadata": {}, "score": "119.71012"}
{"text": "Allocation : Randomized ; Endpoint Classification : Efficacy Study ; Intervention Model : Parallel Assignment ; Masking : Double Blind ( Subject , Investigator , Outcomes Assessor ) ; Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "120.057495"}
{"text": "A meta - analysis of randomized trials found no benefit for DAART relative to SAT for viral load suppression [ 2 ] .In contrast , a second meta - analysis , which included both randomized and non - randomized comparative studies , found DAART to be statistically significantly associated with a higher likelihood of viral suppression and larger CD4 cell increases compared to SAT [ 3 ] .", "label": "", "metadata": {}, "score": "120.16403"}
{"text": "Research assistants did not discuss EAM data or provide feedback to participants .We reimbursed participants for attending EAM visits and returning EAM devices .We modified the procedures described above for participants assigned to DAART .", "label": "", "metadata": {}, "score": "120.658005"}
{"text": "Fourth , as has been done in other studies [ 33 - 35 ] , we will assess the effect of DAART on the acquisition of new drug resistance mutations .", "label": "", "metadata": {}, "score": "120.70177"}
{"text": "Top HIV Med 2009 , 17 : 138 - 145 .PubMed .Andresen EM , Malmgren JA , Carter WB , Patrick DL : Screening for depression in well older adults : evaluation of a short form of the CES - D ( Center for Epidemiologic Studies Depression Scale ) .", "label": "", "metadata": {}, "score": "120.77272"}
{"text": "Atripla ( efavirenz [ EFV ] 150 mg / FTC 200 mg / TDF 300 mg ) QHS and placebo to match Stribild QD were administered during the double blind phase .", "label": "", "metadata": {}, "score": "121.33717"}
{"text": "Reporting Groups .Description .Stribild .Stribild QD was administered during the extension phase .Atripla .Atripla ( efavirenz [ EFV ] 150 mg / FTC 200 mg / TDF 300 mg ) QHS and placebo to match Stribild QD were administered during the double blind phase .", "label": "", "metadata": {}, "score": "121.81251"}
{"text": "PubMed .Derogatis LR , Melisaratos N : The Brief Symptom Inventory : an introductory report .Psychol Med 1983 , 13 : 595 - 605 .", "label": "", "metadata": {}, "score": "121.9025"}
{"text": "The DAART intervention is 12 months .To assess persistence of any study arm differences that emerge during the active intervention , we are conducting an 18-month visit ( 6 months after the intervention concludes ) .", "label": "", "metadata": {}, "score": "122.46109"}
{"text": "PubMed View Article .Celentano DD , Galai N , Sethi AK , Shah NG , Strathdee SA , Vlahov D , et al .: Time to initiating highly active antiretroviral therapy among HIV - infected injection drug users .", "label": "", "metadata": {}, "score": "122.8354"}
{"text": "Research assistants met with participants to initiate EAM when the new regimen was started .Research assistants instructed participants on the use of EAM devices ( with verbal and written instructions ) , activated new EAM caps , completed quality control protocols , and placed caps on medication bottles .", "label": "", "metadata": {}, "score": "123.16081"}
{"text": "PubMed View Article .Johnson VA , Brun - Vezinet F , Clotet B , Gunthard HF , Kuritzkes DR , Pillay D , et al .", "label": "", "metadata": {}, "score": "123.31638"}
{"text": "Outcome of Treatment for PCP - Positive Patients Enrolled in the TMP - SMX Comparative Study .The failure rate due to lack of response was significantly larger for patients receiving MEPRON while the failure rate due to adverse experiences was significantly larger for patients receiving TMP - SMX .", "label": "", "metadata": {}, "score": "123.32204"}
{"text": "Insulin Lispro , Then Aspart - PH20 .Participants received a SC injection of 100 U / mL insulin lispro alone pre - meals for 12 weeks during Treatment Period 1 of the study .", "label": "", "metadata": {}, "score": "123.581375"}
{"text": "Measure Description .Time Frame .Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "123.847145"}
{"text": "The primary analysis of viral suppression will be intent - to - treat , with missing values excluded .In sensitivity analyses , we will consider missing values to be failures and construct bounds for the potential bias .", "label": "", "metadata": {}, "score": "124.082954"}
{"text": "Reconstituted solution using Clopidogrel powder administered once daily with a graduated syringe in the mouth or via a feeding tube .Explanation of how the number of participants for analysis was determined .", "label": "", "metadata": {}, "score": "124.57227"}
{"text": "PubMed View Article .Gourevitch MN , Friedland GH : Interactions between methadone and medications used to treat HIV infection : A review [ In Process Citation].", "label": "", "metadata": {}, "score": "124.74754"}
{"text": "PubMed View Article .Bangsberg DR , Mundy LM , Tulsky JP : Expanding directly observed therapy : tuberculosis to human immunodeficiency virus .Am J Med 2001 , 110 : 664 - 666 .", "label": "", "metadata": {}, "score": "125.05296"}
{"text": "CYP2C19 contribute to proguanil metabolism .CYP2C19 genotype will be determined in atovaquone / proguanil dosing group .The efficacy and safety of both drug combination as well as evidence for in vivo and in vitro resistance to their components will be monitored during the treatment period .", "label": "", "metadata": {}, "score": "125.22841"}
{"text": "Aspart - PH20 , Then Insulin Lispro .Participants received SC injection of 100 U / mL insulin aspart and 5 \u00b5g rHuPH20 ( Aspart - PH20 ) pre - meals for 12 weeks during Treatment Period 1 of the study .", "label": "", "metadata": {}, "score": "125.32341"}
{"text": "Discussion .This study is designed to assess the efficacy of DAART compared to SAT among HIV - infected subjects attending OTPs for maintenance methadone or buprenorphine therapy , and builds upon our developmental work with DAART in this setting [ 7 , 18 ] .", "label": "", "metadata": {}, "score": "125.341034"}
{"text": "PubMed View Article .Saunders JB , Aasland OG , Babor TF , de lF Jr , Grant M : Development of the Alcohol Use Disorders Identification Test ( AUDIT ) : WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption -- II .", "label": "", "metadata": {}, "score": "125.54801"}
{"text": "Atripla .Atripla QHS and placebo to match Stribild QD were administered during the double blind phase .All Stribild .The All Stribild safety analysis set included all participants who received at least 1 dose of Stribild in the randomized phase or in the open - label extension phase .", "label": "", "metadata": {}, "score": "125.62727"}
{"text": "Allocation : Randomized ; Endpoint Classification : Safety / Efficacy Study ; Intervention Model : Parallel Assignment ; Masking : Double Blind ( Subject , Caregiver , Investigator , Outcomes Assessor ) ; Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "125.6492"}
{"text": "Participants were treated until disease progression , unacceptable toxicity , or consent withdrawal .Placebo With Paclitaxel .Participants received matching placebo orally OD with paclitaxel ( 175 mg / m^2 IV ) over the course of 3 hours , every 3 weeks .", "label": "", "metadata": {}, "score": "125.71244"}
{"text": "Participants were treated until disease progression , unacceptable toxicity , or consent withdrawal .Placebo With Paclitaxel .Participants received matching placebo orally OD with paclitaxel ( 175 mg / m^2 IV ) over the course of 3 hours , every 3 weeks .", "label": "", "metadata": {}, "score": "125.71244"}
{"text": "We used a second EAM device to monitor observed doses delivered at the OTP .For observed doses , the research assistant removed a dose from the EAM device and gave it to the participant to take ( in addition to other medications used in the regimen ) .", "label": "", "metadata": {}, "score": "126.24095"}
{"text": "This may be a positive finding that reflects improving access to ART among HIV - infected drug users during the study period compared to the late 1990s [ 37 ] .", "label": "", "metadata": {}, "score": "126.785324"}
{"text": "S402-S408 PubMed View Article .Altice FL , Friedland GH , Cooney EL : Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone .", "label": "", "metadata": {}, "score": "127.20274"}
{"text": "Reporting Groups .Description .Placebo .Reconstituted solution using Clopidogrel matching placebo powder administered once daily with a graduated syringe in the mouth or via a feeding tube .", "label": "", "metadata": {}, "score": "127.24842"}
{"text": "a Values are frequency ( % ) or median ( interquartile range ) .b Center for Epidemiologic Studies Depression ( CES - D ) Scale ( 7 ) .", "label": "", "metadata": {}, "score": "127.31221"}
{"text": "Table 5 .Outcome of Treatment for PCP - Positive Patients Enrolled in the Pentamidine Comparative Study .Atovaquone - proguanil for treating uncomplicated malaria .", "label": "", "metadata": {}, "score": "127.414406"}
{"text": "Includes whether analysis was per protocol , intention to treat , or another method .Also provides relevant details such as imputation technique , as appropriate .", "label": "", "metadata": {}, "score": "128.03856"}
{"text": "Includes whether analysis was per protocol , intention to treat , or another method .Also provides relevant details such as imputation technique , as appropriate .", "label": "", "metadata": {}, "score": "128.03856"}
{"text": "PCP event rates are shown in Table 3 .There was no significant difference in mortality rates between the groups .Aerosolized Pentamidine Comparative Study .", "label": "", "metadata": {}, "score": "128.26602"}
{"text": "However , we discontinued recruitment at site 3 due to slow enrollment and replaced it with sites 4 and 5 in August 2007 and August 2008 , respectively .", "label": "", "metadata": {}, "score": "128.33267"}
{"text": "Insulin Lispro , Then Lispro - PH20 .Participants received a subcutaneous ( SC ) injection of 100 units per milliliter ( U / mL ) insulin lispro alone pre - meals for 12 weeks during Treatment Period 1 of the study .", "label": "", "metadata": {}, "score": "129.31866"}
{"text": "Finally , we will compare EAM in the study arms .We will use chi - squared and Wilcoxon rank sum tests to compare categorical and continuous variables , respectively .", "label": "", "metadata": {}, "score": "129.32611"}
{"text": "An analysis of all PCP events ( intent - to - treat analysis ) showed results similar to those above .Treatment of PCP .The indication for treatment of mild - to - moderate PCP is based on the results of comparative pharmacokinetic studies of the suspension and tablet formulations ( see CLINICAL PHARMACOLOGY ) and clinical efficacy studies of the tablet formulation which established a relationship between plasma atovaquone concentration and successful treatment .", "label": "", "metadata": {}, "score": "129.34224"}
{"text": "We stored plasma samples from baseline and follow - up visits so that acquisition of drug resistance during the study period can be assessed .Urine samples were screened for methadone , opiates , cocaine , oxycodone , and benzodiazepines by enzyme immunoassay .", "label": "", "metadata": {}, "score": "129.79077"}
{"text": "Moreover , labor intensive adherence interventions are most likely to be cost - effective when delivered to those at highest risk of poor outcomes [ 31 ] .", "label": "", "metadata": {}, "score": "130.16327"}
{"text": "We maintained close contact with the medical providers and asked them to notify us promptly of changes to the ART regimen and to send new prescriptions to us by facsimile so that medication could be prepared for observed dosing .", "label": "", "metadata": {}, "score": "130.19406"}
{"text": "Additional Description .No text entered .Frequency Threshold .Threshold above which other adverse events are reported .Reporting Groups .Description .Stribild .", "label": "", "metadata": {}, "score": "130.54626"}
{"text": "The participant 's prestudy ritonavir - boosted PI was continued unmodified through the 48 weeks of the study .Abacavir ( ABC ) /Lamivudine ( 3TC ) + PI / r ( Ritonavir - boosted PI ) .", "label": "", "metadata": {}, "score": "130.62007"}
{"text": "Death .[ 1 ] .Participants were randomized to the Insulin lispro or an Analog - PH20 group after titration .[ 2 ] .", "label": "", "metadata": {}, "score": "130.7694"}
{"text": "PubMed View Article .Pre - publication history .Copyright .\u00a9 Mullen et al ; licensee BioMed Central Ltd. 2011 .Key information relevant to the recruitment process for the overall study , such as dates of the recruitment period and locations .", "label": "", "metadata": {}, "score": "131.50879"}
{"text": "Background .Founded on the successful model of directly observed therapy for tuberculosis [ 1 ] , directly administered antiretroviral therapy ( DAART ) for HIV - infected individuals has been evaluated in several contexts [ 2 - 4 ] .", "label": "", "metadata": {}, "score": "132.38327"}
{"text": "Description .Analog - PH20 .100 U / mL insulin analog ( insulin lispro or insulin aspart ) with 5.0 \u00b5g / mL rHuPH20 , injected SC , pre - meals , with doses titrated to each participant individually , for 12 weeks .", "label": "", "metadata": {}, "score": "132.51093"}
{"text": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days .", "label": "", "metadata": {}, "score": "132.8621"}
{"text": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days .", "label": "", "metadata": {}, "score": "132.8621"}
{"text": "While other investigators have administered ART and methadone simultaneously from OTP dosing windows [ 6 , 14 ] , participants in our pilot project found that this approach was stressful and jeopardized their confidentiality [ 7 ] .", "label": "", "metadata": {}, "score": "133.82503"}
{"text": "Description .LMHF Mechanical Stimulation .Low magnitude , high frequency mechanical stimulation device ( \" vibrating \" ) platform .LMHF mechanical stimulation active device : Participants were randomly assigned to stand on a low magnitude , high frequency mechanical stimulation device ( \" vibrating \" ) platform for 10 minutes twice daily for one year .", "label": "", "metadata": {}, "score": "133.94469"}
{"text": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days .", "label": "", "metadata": {}, "score": "134.04605"}
{"text": "Last participant observation ( LPO ) date was 19 April 2011 .Pre - Assignment Details .Significant events and approaches for the overall study following participant enrollment , but prior to group assignment .", "label": "", "metadata": {}, "score": "134.90607"}
{"text": "The sponsor can not require changes to the communication and can not extend the embargo .The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days .", "label": "", "metadata": {}, "score": "134.9918"}
{"text": "The sponsor can not require changes to the communication and can not extend the embargo .The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days .", "label": "", "metadata": {}, "score": "134.9918"}
{"text": "ABC/3TC + PI / r .Participants in this group continued their prestudy therapy - ABC 600 mg/3TC 300 mg administered as one tablet orally once daily ( Epzicom ) plus ritonavir - boosted PI regimen , given orally for 48 weeks .", "label": "", "metadata": {}, "score": "135.0386"}
{"text": "Safety Monitoring .We alerted patients and HIV medical providers about potential drug interactions between methadone and antiretroviral drugs that were prescribed .In particular , we assured that participants and providers were aware of the potential for non - nucleoside reverse transcriptase inhibitors to increase the metabolism of methadone , which can cause clinically significant opioid withdrawal symptoms [ 15 , 16 ] .", "label": "", "metadata": {}, "score": "135.04582"}
{"text": "Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed .Restriction Description : If no publication has occurred within 12 months after trial completion , the Investigator can publish the results .", "label": "", "metadata": {}, "score": "135.21991"}
{"text": "Reporting Groups .Description .LMHF Mechanical Stimulation .Low magnitude , high frequency mechanical stimulation device ( \" vibrating \" ) platform .LMHF mechanical stimulation active device : Participants were randomly assigned to stand on a low magnitude , high frequency mechanical stimulation device ( \" vibrating \" ) platform for 10 minutes twice daily for one year .", "label": "", "metadata": {}, "score": "136.08191"}
{"text": "We stored hard copies of study records in locked filing cabinets inside locked offices .We store electronic data on a password - protected laptop computer that was backed - up each night to a secure server .", "label": "", "metadata": {}, "score": "136.35995"}
{"text": "Lispro - PH20 , Then Insulin Lispro .Participants received a SC injection of 100 U / mL insulin lispro and 5 \u00b5g rHuPH20 ( Lispro - PH20 ) pre - meals for 12 weeks during Treatment Period 1 of the study .", "label": "", "metadata": {}, "score": "136.79051"}
{"text": "Type of systemic - to - pulmonary artery shunt palliation [ 1 ] [ units : participants ] .Yes .Age at shunt palliation [ units : days ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "136.90292"}
{"text": "We reimbursed participants for completing study visits .DAART Arm .Two specialty pharmacies packaged medications for the DAART arm in single - dose clear plastic bags that were labeled with medication and dosing information as specified in Maryland State regulations .", "label": "", "metadata": {}, "score": "137.23456"}
{"text": "To see if ARV drugs atazanavir - ritonavir or efavirenz lower the blood levels of .atovaquone .Eligibility : . -Individuals between 18 and 70 years of age who have HIV .", "label": "", "metadata": {}, "score": "137.24173"}
{"text": "In the DAART arm , EAM will be done for both observed doses at the OTP and for self - administered doses taken on nights and weekends .", "label": "", "metadata": {}, "score": "137.80043"}
{"text": "Reporting Groups .Description .Lapatinib With Paclitaxel .Participants received lapatinib 1500 milligrams ( mg ) orally once daily ( OD ) with paclitaxel 175 mg / meters squared ( m^2 ) intravenously ( IV ) over the course of 3 hours , every 3 weeks .", "label": "", "metadata": {}, "score": "138.37933"}
{"text": "Reporting Groups .Description .Lapatinib With Paclitaxel .Participants received lapatinib 1500 milligrams ( mg ) orally once daily ( OD ) with paclitaxel 175 mg / meters squared ( m^2 ) intravenously ( IV ) over the course of 3 hours , every 3 weeks .", "label": "", "metadata": {}, "score": "138.37933"}
{"text": "Authors ' contributions .All authors have read , contributed to , and approved the manuscript .Authors ' Affiliations .Division of Infectious Diseases , Department of Medicine , Johns Hopkins University School of Medicine .", "label": "", "metadata": {}, "score": "139.58179"}
{"text": "Drug : Insulin lispro Drug : Insulin aspart Drug : Recombinant human hyaluronidase PH20 Drug : Insulin glulisine Drug : Insulin glargine .Key information relevant to the recruitment process for the overall study , such as dates of the recruitment period and locations .", "label": "", "metadata": {}, "score": "139.8964"}
{"text": "Large trials comparing atovaquone - proguanil with other new combination therapies are needed .Clinical Trials Related to Mepron ( Atovaquone ) .Serial blood samples will be collected for the determination of the plasma concentration of atovaquone , proguanil and cycloguanil after dosing of atovaquone 1000mg / proguanil 400 mg and the plasma atovaquone concentration of atovaquone 750 and 1500 mg .", "label": "", "metadata": {}, "score": "141.68878"}
{"text": "Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed .Restriction Description : .", "label": "", "metadata": {}, "score": "143.2266"}
{"text": "Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed .Restriction Description : .", "label": "", "metadata": {}, "score": "143.2266"}
{"text": "Emergency doses are replenished as needed .SAT Arm .SAT participants self - administered all ART doses .We did not provide adherence counseling , coaching , or feedback to SAT participants .", "label": "", "metadata": {}, "score": "143.26591"}
{"text": "PubMed View Article .Flanigan TP , Mitty JA : The Good , the Bad , and the Ugly : Providing Highly Active Antiretroviral Therapy When It Is Most Difficult .", "label": "", "metadata": {}, "score": "143.79489"}
{"text": "Department of Psychiatry and Behavioral Sciences , Johns Hopkins University School of Medicine .Department of Medicine , University of Maryland School of Medicine .References .", "label": "", "metadata": {}, "score": "144.89404"}
{"text": "AIDS patients with toxoplasmic encephalitis who receive the standard therapy combination of sulfadiazine and pyrimethamine experience a high frequency of severe toxicity .Atovaquone , an antibiotic that has demonstrated efficacy against toxoplasmosis in animal models and in preclinical testing has been well tolerated , is now available as a suspension , which is more readily absorbed than the tablet form of the drug .", "label": "", "metadata": {}, "score": "144.95114"}
{"text": "PubMed .Centers for Disease Control and Prevention : 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults .", "label": "", "metadata": {}, "score": "145.33546"}
{"text": "However , some ARV drugs may make other drugs used to treat PCP and toxoplasmosis less effective .Researchers want to test specific ARV drugs to see if they affect atovaquone , a drug used to treat PCP and toxoplasmosis .", "label": "", "metadata": {}, "score": "145.43512"}
{"text": "The approval is given in writing by the sponsor , not exceeding 90 days .Mepron News .MEPRON SUMMARY .MEPRON Suspension is indicated for the prevention of Pneumocystis carinii pneumonia in patients who are intolerant to trimethoprim - sulfamethoxazole ( TMP - SMX ) .", "label": "", "metadata": {}, "score": "148.91277"}
{"text": "Body Mass Index ( BMI ) [ units : kg / m^2 ] Mean ( Standard Deviation ) Abstract .Background .HIV - infected drug users are at higher risk of non - adherence and poor treatment outcomes than HIV - infected non - drug users .", "label": "", "metadata": {}, "score": "151.22826"}
{"text": "Division of Pulmonary and Critical Care , Department of Medicine , Johns Hopkins University School of Medicine .Department of Epidemiology , Bloomberg School of Public Health , Johns Hopkins University .", "label": "", "metadata": {}, "score": "151.34415"}
{"text": "Electronic Adherence Monitoring .We used MEMS VI Track Caps ( Aardex Group , Zug , Switzerland ) for electronic adherence monitoring ( EAM ) for the first 2 months of the study in both arms .", "label": "", "metadata": {}, "score": "152.72122"}
{"text": "Medication assisted therapy with methadone or buprenorphine in opioid treatment programs ( OTPs ) is effective treatment for opioid addiction , and entails frequent contact with patients that may facilitate DAART [ 5 , 6 ] .", "label": "", "metadata": {}, "score": "152.75157"}
{"text": "- People who are infected with the human immunodeficiency virus ( HIV ) are at risk of getting . certain diseases .Two of these diseases are a type of pneumonia known as PCP and a brain infection called toxoplasmosis .", "label": "", "metadata": {}, "score": "152.90225"}
{"text": "There are insufficient data for comparisons against sulfadoxine - pyrimethamine , halofantrine , artesunate plus mefloquine , quinine plus tetracycline , and dihydroartemisinin - piperaquine - trimethoprim - primaquine in treating malaria .", "label": "", "metadata": {}, "score": "153.08551"}
{"text": "Analog - PH20 .Insulin Lispro .Number of Participants Analyzed [ units : participants ] .Percentage of Participants Meeting Glucose Targets at Least 2/3 of the Time [ units : Percentage of participants ] .", "label": "", "metadata": {}, "score": "157.7464"}
{"text": "Also provides relevant details such as imputation technique , as appropriate .Sweden .Weight [ units : kilograms ( kg ) ] Mean ( Standard Deviation ) .", "label": "", "metadata": {}, "score": "163.724"}
{"text": "Placebo Device .The placebo device is identical in appearance and function to the active platform ; except when activated , it emits the same sound as the active device but does not deliver the vibration .", "label": "", "metadata": {}, "score": "166.7113"}
{"text": "Placebo Device .The placebo device is identical in appearance and function to the active platform ; except when activated , it emits the same sound as the active device but does not deliver the vibration .", "label": "", "metadata": {}, "score": "166.7113"}
